mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.04 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.04 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.04 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |